GlassScriptPhysician profile
Seth M Hale
NPI 1144666025
$8,030.56
in general payments reported to CMS, 2019-2025
22 companies · $679 in 2025
The $679 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,449 · 2020: $874 · 2021: $758 · 2022: $2,052 · 2023: $578 · 2024: $640 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,897.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,928.48 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Linq II |
| Medtronic Vascular, INC. | $1,373.28 | 2019-2020 | |
| Edwards Lifesciences Corporation | $883.32 | 2019 | |
| Biosense Webster, INC. | $606.75 | 2023-2025 | Carto 3 |
| Abbott Laboratories | $532.54 | 2019-2024 | Pressurewire |
| Novartis Pharmaceuticals Corporation | $504.91 | 2021-2024 | |
| Abiomed | $494.72 | 2019-2023 | Impella |
| E.R. Squibb & Sons, L.L.C. | $320.37 | 2022-2025 | Camzyos, Eliquis |
| Penumbra, INC. | $277.52 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $215.60 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $195.05 | 2021-2023 | Verquvo |
| Boston Scientific Corporation | $123.04 | 2019-2025 | Emblem Mri S-Icd |
| Pfizer INC. | $111.43 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $91.05 | 2020-2022 | |
| Amgen INC. | $89.20 | 2021-2023 | Repatha |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.18 | 2022-2023 | Jardiance |
| Shockwave Medical, INC | $54.68 | 2025 | |
| Sanofi-Aventis U.S. LLC | $48.18 | 2021-2024 | |
| Philips North America LLC | $44.43 | 2020-2024 | (P88) Igt Devices Fm |
| Terumo Medical Corporation | $37.97 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $27.09 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Hale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.